DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Avience Biomedicals Limited (AVIENCE) share price today?

Avience Biomedicals Limited (AVIENCE) is trading at ₹273.9 on the NSE, down 1.12% on the day. Source: DocStoX.

What is the PE ratio of Avience Biomedicals Limited?

Avience Biomedicals Limited has a price-to-earnings (PE) ratio of 12.6 in the Healthcare sector.

What is the market capitalisation of Avience Biomedicals Limited?

Avience Biomedicals Limited has a market capitalisation of approximately ₹146 crore.

Is Avience Biomedicals Limited a profitable company?

Avience Biomedicals Limited generates a return on equity of 27.9% with a net profit margin of 16.7%. That is a strong return on shareholder capital.

What is the 52-week high and low of AVIENCE?

Avience Biomedicals Limited (AVIENCE) has traded between ₹222 and ₹414.95 over the past 52 weeks, against a current price of ₹273.9.

Avience Biomedicals Limited

₹273.90▼ -3.10 (-1.12%)

AVIENCE·NSE·Healthcare

Market Cap

146.40 Cr

PE Ratio

12.62

Volume

2,400

Day High - Low

273.90 - 270.50

52W High-Low

414.95 - 222.00

₹273.90▼ -3.10 (-1.12%)

Market Cap146.40 Cr

PE Ratio12.62

Volume2,400

Day High - Low273.90 - 270.50

52W High-Low414.95 - 222.00

Avience Biomedicals Limited (AVIENCE): company summary

Annual revenue rose 16.9% to ₹53 crore, while annual net profit rose 23.2% to ₹9 crore.

Avience Biomedicals Limited (AVIENCE) is a micro-cap Healthcare company valued at ₹146 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move: Avience Biomedicals Limited last traded at ₹273.9, modestly down 1.12% on the day.
Recent developments: 2026-06-25: Avience Biomedicals debuted on the NSE SME platform. 2026-06-26: The company's IPO had a Grey Market Premium today.
Financial performance: Annual revenue rose 16.9% to ₹53 crore, while annual net profit rose 23.2% to ₹9 crore. The latest quarter revenue rose 5.0% to ₹26 crore, but net profit fell 1.2% to ₹4 crore. The net profit margin increased 0.9 percentage points to 16.7%, and return on equity remained at 27.9%.
Valuation multiples: The stock trades at 12.6 times earnings, a discount to the Healthcare median of 32.0, 2.10 times book value.
Things to watch: The stock is 22.0% below its 52-week high. The company is not paying out dividends despite repeated profits. The net profit for the latest quarter fell 1.2% compared to the same quarter a year earlier.
Where it stands: Avience Biomedicals reported annual revenue and net profit growth, but the latest quarter net profit fell slightly. The stock is trading 22.0% below its 52-week high. The company is not paying dividends.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

6.8/10

Fair

Fair Value

ROE

27.86%

Strong

P/E

12.62x

Cheap

Debt / Equity

0.92

Moderate

Industry

Healthcare

Medical Equipment & Supplies

Overall View

Mixed

Price performance

Day₹270.50

₹273.90

52W₹222.00

₹414.95

DocStoX take

Supported by valuation (9.0) and quality (7.9), but held back by momentum (1.7). Valuation looks strong at 9.0, but that is offset by momentum at 1.7. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence

6.8

/10

Fair

Quality

Excellent

ROE 27.9%

Valuation

Cheap

P/E 12.6×

Growth

No data

No multi-year history

Risk

Moderate

D/E 0.92

Momentum

Weak

27% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹274

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹146 Cr

52W High / Low

₹415 / ₹222

Dividend Yield

0.00%

Promoter Holding

64.59%

EPS (TTM)

₹21.71

Book Value

₹77.92

Key highlights

Strong returns on equity (28%)
Undemanding at 13× earnings
Capital works hard — ROCE 23%
Momentum is weak (1.7/10)
Small ₹146 cr company — thinner liquidity

4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Medical Equipment & Supplies

Explore Avience Biomedicals Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Avience Biomedicals Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Avience Biomedicals Limited with peers

Avience Biomedicals Limited vs Sun Pharmaceutical Industries Limited Avience Biomedicals Limited vs Divi's Laboratories Limited Avience Biomedicals Limited vs Torrent Pharmaceuticals Limited Avience Biomedicals Limited vs Apollo Hospitals Enterprise Limited Avience Biomedicals Limited vs Zydus Lifesciences Limited Avience Biomedicals Limited vs Laurus Labs Limited

Related tools & concepts

Value Avience Biomedicals Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

AVIENCE newsLatest coverage & filings Open screenerFilter the whole market